Literature DB >> 6319818

Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine II. A HPLC procedure.

M A ElSohly, H N ElSohly, A B Jones, P A Dimson, K E Wells.   

Abstract

A high performance liquid chromatographic (HPLC) procedure was developed for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine. Hydrolyzed urine samples were cleaned up using Bond-Elut columns. 11-Nor-cannabinol-9-carboxylic acid was used as internal standard. The analysis was carried out using a C8 reversed-phase column with acetonitrile:50 mM phosphoric acid (65:35) as the solvent. Detection was done by ultraviolet detector at 214 nm. The minimum detectable level of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid was 25 ng/mL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319818     DOI: 10.1093/jat/7.6.262

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine.

Authors:  F Musshoff; T Daldrup
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

2.  Maternal marijuana use and neonatal outcome: uncertainty posed by self-reports.

Authors:  R Hingson; B Zuckerman; H Amaro; D A Frank; H Kayne; J R Sorenson; J Mitchell; S Parker; S Morelock; R Timperi
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

3.  Violence during pregnancy and substance use.

Authors:  H Amaro; L E Fried; H Cabral; B Zuckerman
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.